Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-escalation of Rectal Indomethacin for Post-ERCP Pancreatitis Prevention in High-risk Patients: Protocol of a Multicentre Randomised Clinical Trial

NCT07247682 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Anhui Medical University as lead sponsor.

NCT NCT07247682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07247682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-escalation of Rectal Indomethacin for Post-ERCP Pancreatitis Prevention in High-risk Patients: Protocol of a Multicentre Randomised Clinical Trial
Lead sponsor
The First Affiliated Hospital of Anhui Medical University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 30, 2028
Enrollment
1,036 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis